Gilead Sciences, Inc.
CH ˙ SWX ˙ US3755581036
SecurityCH:GILD / Gilead Sciences, Inc.
InstitutionVictory Capital Management Inc
Latest Disclosed Ownership2,161,094 shares
Latest Disclosed Value $ 301,191,718
Victory Capital Management Inc reports 20.88% decrease in ownership of GILD / Gilead Sciences, Inc.

On May 15, 2026 - Victory Capital Management Inc filed a 13F-HR form disclosing ownership of 2,161,094 shares of Gilead Sciences, Inc. (CH:GILD) valued at $301,191,718 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 2,731,286 shares of Gilead Sciences, Inc.. This represents a change in shares of -20.88% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F GILEAD SCIENCES COM 375558103 2,161,094 -570,192 -20.88 301,192 -10.16 0.1446
2026-02-13 2025-12-31 13F GILEAD SCIENCES COM 375558103 2,731,286 -109,808 -3.86 335,238 6.30 0.1892
2025-11-12 2025-09-30 13F GILEAD SCIENCES COM 375558103 2,841,094 50,955 1.83 315,361 1.93 0.1844
2025-08-13 2025-06-30 13F GILEAD SCIENCES COM 375558103 2,790,139 319,122 12.91 309,402 11.75 0.1995
2025-05-02 2025-03-31 13F GILEAD SCIENCES COM 375558103 2,471,017 -580,550 -19.02 276,877 -1.77 0.2833
2025-02-06 2024-12-31 13F GILEAD SCIENCES COM 375558103 3,051,567 489,955 19.13 281,873 31.25 0.2771
2024-11-05 2024-09-30 13F GILEAD SCIENCES COM 375558103 2,561,612 -468,814 -15.47 214,766 3.29 0.2069
2024-08-05 2024-06-30 13F GILEAD SCIENCES COM 375558103 3,030,426 737,109 32.14 207,918 23.77 0.2084
2024-05-03 2024-03-31 13F GILEAD SCIENCES COM 375558103 2,293,317 -196,388 -7.89 167,985 -16.71 0.1640
2024-02-05 2023-12-31 13F GILEAD SCIENCES COM 375558103 2,489,705 178,536 7.72 201,691 16.45 0.2122
2023-11-06 2023-09-30 13F GILEAD SCIENCES COM 375558103 2,311,169 137,272 6.31 173,199 3.38 0.1991
2023-07-27 2023-06-30 13F GILEAD SCIENCES COM 375558103 2,173,897 -204,654 -8.60 167,542 -15.10 0.1843
2023-05-02 2023-03-31 13F GILEAD SCIENCES COM 375558103 2,378,551 17,600 0.75 197,348 -2.63 0.2216
2023-04-25 2022-12-31 13F/A-3 GILEAD SCIENCES COM 375558103 2,360,951 -147,980 -5.90 202,688 30.96 0.2332
2023-03-10 2022-12-31 13F/A-2 GILEAD SCIENCES COM 375558103 2,360,951 -147,980 202,688 0.2213
2023-02-10 2022-12-31 13F/A-1 GILEAD SCIENCES COM 375558103 2,360,951 -147,980 202,688 0.1398
2023-02-09 2022-12-31 13F GILEAD SCIENCES COM 375558103 2,320,289 -188,642 194,765 0.1323
2022-11-02 2022-09-30 13F GILEAD SCIENCES COM 375558103 2,508,931 48,312 1.96 154,776 1.77 0.1806
2022-08-01 2022-06-30 13F GILEAD SCIENCES COM 375558103 2,460,619 158,356 6.88 152,091 11.33 0.1733
2022-05-04 2022-03-31 13F GILEAD SCIENCES COM 375558103 2,302,263 403,107 21.23 136,616 -0.93 0.1367
2022-02-07 2021-12-31 13F GILEAD SCIENCES COM 375558103 1,899,156 309,064 19.44 137,898 24.16 0.1269
2021-11-02 2021-09-30 13F GILEAD SCIENCES COM 375558103 1,590,092 -374,703 -19.07 111,068 -17.91 0.1088
2021-08-03 2021-06-30 13F GILEAD SCIENCES COM 375558103 1,964,795 520,313 36.02 135,296 44.92 0.1299
2021-05-04 2021-03-31 13F GILEAD SCIENCES COM 375558103 1,444,482 311,832 27.53 93,357 41.48 0.0957
2021-02-01 2020-12-31 13F GILEAD SCIENCES COM 375558103 1,132,650 165,963 17.17 65,988 8.03 0.0735
2020-11-09 2020-09-30 13F Gilead Sciences COM 375558103 966,687 -6,062 -0.62 61,085 -18.38 0.0784
2020-08-07 2020-06-30 13F GILEAD SCIENCES COM 375558103 972,749 -91,746 -8.62 74,843 -5.95 0.1014
2020-05-12 2020-03-31 13F/A-1 GILEAD SCIENCES COM 375558103 1,064,495 -153,784 -12.62 79,582 0.53 0.1334
2020-05-04 2020-03-31 13F GILEAD SCIENCES COM 375558103 1,064,495 -153,784 79,582 87,094.4121
2020-02-06 2019-12-31 13F/A-1 GILEAD SCIENCES COM 375558103 1,218,279 -107,920 -8.14 79,164 -5.82 0.0961
2020-02-04 2019-12-31 13F GILEAD SCIENCES COM 375558103 1,196,951 -129,248 75,647 90,677.3513
2019-11-12 2019-09-30 13F GILEAD SCIENCES COM 375558103 1,326,199 1,091,511 465.09 84,054 430.11 0.1081
2019-08-15 2019-06-30 13F GILEAD SCIENCES COM 375558103 234,688 14,266 6.47 15,856 10.65 0.0320
2019-05-03 2019-03-31 13F GILEAD SCIENCES CS 375558103 220,422 201,305 1,053.02 14,330 1,098.16 0.0326
2019-05-02 2018-12-31 13F/A-1 GILEAD SCIENCES COM 375558103 19,117 -127 -0.66 1,196 -19.52 0.0030
2019-02-05 2018-12-31 13F GILEAD SCIENCES COM 375558103 19,117 -127 1,196
2018-11-01 2018-09-30 13F GILEAD SCIENCES COM 375558103 19,244 -569 -2.87 1,486 5.84 0.0031
2018-08-02 2018-06-30 13F GILEAD SCIENCES COM 375558103 19,813 -411 -2.03 1,404 -7.93 0.0030
2018-05-04 2018-03-31 13F GILEAD SCIENCES COM 375558103 20,224 -22,758 -52.95 1,525 -50.47 0.0033
2018-02-01 2017-12-31 13F GILEAD SCIENCES COM 375558103 42,982 -158,423 -78.66 3,079 -81.13 0.0065
2017-10-27 2017-09-30 13F GILEAD SCIENCES COM 375558103 201,405 -78,965 -28.16 16,318 -17.77 0.0367
2017-08-07 2017-06-30 13F GILEAD SCIENCES COM 375558103 280,370 119,567 74.36 19,844 81.69 0.0465
2017-05-10 2017-03-31 13F GILEAD SCIENCES COM 375558103 160,803 62,693 63.90 10,922 55.45 0.0260
2017-02-09 2016-12-31 13F GILEAD SCIENCES COM 375558103 98,110 22,310 29.43 7,026 17.14 0.0177
2016-11-02 2016-09-30 13F GILEAD SCIENCES COM 375558103 75,800 10,910 16.81 5,998 10.81 0.0168
2016-08-09 2016-06-30 13F GILEAD SCIENCES COM 375558103 64,890 -133,421 -67.28 5,413 -70.29 0.0217
2016-05-17 2016-03-31 13F/A-2 GILEAD SCIENCES COM 375558103 198,311 -295,040 -59.80 18,217 -63.51 0.0752
2016-05-12 2016-03-31 13F/A-1 GILEAD SCIENCES COM 375558103 198,311 0 18,217 0.0748
2016-05-12 2016-03-31 13F GILEAD SCIENCES COM 375558103 198,311 18,217
2016-02-10 2015-12-31 13F GILEAD SCIENCES COM 375558103 493,351 -206,094 -29.47 49,923 -27.31 0.2073
2015-11-06 2015-09-30 13F GILEAD SCIENCES COM 375558103 699,445 -87,780 -11.15 68,679 -25.48 0.2829
2015-08-14 2015-06-30 13F/A-01 GILEAD SCIENCES COM 375558103 787,225 -127,870 -13.97 92,166 2.64 0.3411
2015-08-07 2015-06-30 13F Gilead Sciences COM 375558103 787,225 92,166
2015-05-07 2015-03-31 13F Gilead Sciences COM 375558103 915,095 110,258 13.70 89,799 18.37 0.3226
2015-02-11 2014-12-31 13F GILEAD SCIENCES COM 375558103 804,837 102,347 14.57 75,863 1.45 0.2796
2014-10-16 2014-09-30 13F GILEAD SCIENCES Common Stock 375558103 702,490 -321,921 -31.42 74,781 -11.96 0.5636
2014-08-08 2014-06-30 13F Gilead Sciences Common Stock 375558103 1,024,411 -189,763 -15.63 84,935 -1.28 0.5760
2014-05-06 2014-03-31 13F Gilead Sciences Common Stock 375558103 1,214,174 410,724 51.12 86,036 42.49 0.5838
2014-02-12 2013-12-31 13F Gilead Sciences Common Stock 375558103 803,450 -168,199 -17.31 60,379 -1.12 0.4258
2014-03-12 2013-09-30 13F/A-1 GILEAD SCIENCES Common Stocks 375558103 971,649 971,649 61,064 0.4381
2013-11-12 2013-09-30 13F GILEAD SCIENCES Common Stocks 375558103 971,649 61,064
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.